Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CERo Therapeutics Holdings ( (CERO) ) has issued an update.
Shami Patel, a seasoned financial expert with over 25 years of experience, has been appointed as a Class III director to the board of a company following Dr. Corey’s resignation. Patel’s notable career includes executive and advisory roles in multiple successful SPAC mergers, strategic positions in financial services, and venture capital investments. His diverse background spans from serving as a COO at a major financial corporation to his early days in strategy consulting, underscoring his extensive knowledge in capital markets and his valuable contribution to the board.
See more insights into CERO stock on TipRanks’ Stock Analysis page.